Global Thrombin (Human) Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Thrombin (Human) market size is predicted to grow from US$ 589 million in 2025 to US$ 714 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LP Information, Inc. (LPI) ' newest research report, the “Thrombin (Human) Industry Forecast” looks at past sales and reviews total world Thrombin (Human) sales in 2024, providing a comprehensive analysis by region and market sector of projected Thrombin (Human) sales for 2025 through 2031. With Thrombin (Human) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Thrombin (Human) industry.
This Insight Report provides a comprehensive analysis of the global Thrombin (Human) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Thrombin (Human) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Thrombin (Human) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Thrombin (Human) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Thrombin (Human).
This report presents a comprehensive overview, market shares, and growth opportunities of Thrombin (Human) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Thrombin (Human) market?
What factors are driving Thrombin (Human) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Thrombin (Human) market opportunities vary by end market size?
How does Thrombin (Human) break out by Type, by Application?
The global Thrombin (Human) market size is predicted to grow from US$ 589 million in 2025 to US$ 714 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LP Information, Inc. (LPI) ' newest research report, the “Thrombin (Human) Industry Forecast” looks at past sales and reviews total world Thrombin (Human) sales in 2024, providing a comprehensive analysis by region and market sector of projected Thrombin (Human) sales for 2025 through 2031. With Thrombin (Human) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Thrombin (Human) industry.
This Insight Report provides a comprehensive analysis of the global Thrombin (Human) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Thrombin (Human) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Thrombin (Human) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Thrombin (Human) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Thrombin (Human).
This report presents a comprehensive overview, market shares, and growth opportunities of Thrombin (Human) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 500IU/Vial
- 1000IU/Vial
- 2500IU/Vial
- Biotechnology
- Medicine
- Microbiology
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Baxter
- AMRESCO Inc
- BD Biosciences
- Life Technologies Corporation
- PromoCell GmbH
- Sigma-Aldrich Corporation
- Vitrolife AB
- CSL
- Bayer
- Grifols
- Octapharma
- Shanghai RAAS
- Hualan Biological
- Kedrion
What is the 10-year outlook for the global Thrombin (Human) market?
What factors are driving Thrombin (Human) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Thrombin (Human) market opportunities vary by end market size?
How does Thrombin (Human) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Thrombin (Human) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Thrombin (Human) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Thrombin (Human) by Country/Region, 2020, 2024 & 2031
2.2 Thrombin (Human) Segment by Type
2.2.1 500IU/Vial
2.2.2 1000IU/Vial
2.2.3 2500IU/Vial
2.3 Thrombin (Human) Sales by Type
2.3.1 Global Thrombin (Human) Sales Market Share by Type (2020-2025)
2.3.2 Global Thrombin (Human) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Thrombin (Human) Sale Price by Type (2020-2025)
2.4 Thrombin (Human) Segment by Application
2.4.1 Biotechnology
2.4.2 Medicine
2.4.3 Microbiology
2.4.4 Others
2.5 Thrombin (Human) Sales by Application
2.5.1 Global Thrombin (Human) Sale Market Share by Application (2020-2025)
2.5.2 Global Thrombin (Human) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Thrombin (Human) Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Thrombin (Human) Breakdown Data by Company
3.1.1 Global Thrombin (Human) Annual Sales by Company (2020-2025)
3.1.2 Global Thrombin (Human) Sales Market Share by Company (2020-2025)
3.2 Global Thrombin (Human) Annual Revenue by Company (2020-2025)
3.2.1 Global Thrombin (Human) Revenue by Company (2020-2025)
3.2.2 Global Thrombin (Human) Revenue Market Share by Company (2020-2025)
3.3 Global Thrombin (Human) Sale Price by Company
3.4 Key Manufacturers Thrombin (Human) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Thrombin (Human) Product Location Distribution
3.4.2 Players Thrombin (Human) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR THROMBIN (HUMAN) BY GEOGRAPHIC REGION
4.1 World Historic Thrombin (Human) Market Size by Geographic Region (2020-2025)
4.1.1 Global Thrombin (Human) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Thrombin (Human) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Thrombin (Human) Market Size by Country/Region (2020-2025)
4.2.1 Global Thrombin (Human) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Thrombin (Human) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Thrombin (Human) Sales Growth
4.4 APAC Thrombin (Human) Sales Growth
4.5 Europe Thrombin (Human) Sales Growth
4.6 Middle East & Africa Thrombin (Human) Sales Growth
5 AMERICAS
5.1 Americas Thrombin (Human) Sales by Country
5.1.1 Americas Thrombin (Human) Sales by Country (2020-2025)
5.1.2 Americas Thrombin (Human) Revenue by Country (2020-2025)
5.2 Americas Thrombin (Human) Sales by Type (2020-2025)
5.3 Americas Thrombin (Human) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Thrombin (Human) Sales by Region
6.1.1 APAC Thrombin (Human) Sales by Region (2020-2025)
6.1.2 APAC Thrombin (Human) Revenue by Region (2020-2025)
6.2 APAC Thrombin (Human) Sales by Type (2020-2025)
6.3 APAC Thrombin (Human) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Thrombin (Human) by Country
7.1.1 Europe Thrombin (Human) Sales by Country (2020-2025)
7.1.2 Europe Thrombin (Human) Revenue by Country (2020-2025)
7.2 Europe Thrombin (Human) Sales by Type (2020-2025)
7.3 Europe Thrombin (Human) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Thrombin (Human) by Country
8.1.1 Middle East & Africa Thrombin (Human) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Thrombin (Human) Revenue by Country (2020-2025)
8.2 Middle East & Africa Thrombin (Human) Sales by Type (2020-2025)
8.3 Middle East & Africa Thrombin (Human) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Thrombin (Human)
10.3 Manufacturing Process Analysis of Thrombin (Human)
10.4 Industry Chain Structure of Thrombin (Human)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Thrombin (Human) Distributors
11.3 Thrombin (Human) Customer
12 WORLD FORECAST REVIEW FOR THROMBIN (HUMAN) BY GEOGRAPHIC REGION
12.1 Global Thrombin (Human) Market Size Forecast by Region
12.1.1 Global Thrombin (Human) Forecast by Region (2026-2031)
12.1.2 Global Thrombin (Human) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Thrombin (Human) Forecast by Type (2026-2031)
12.7 Global Thrombin (Human) Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Thrombin (Human) Product Portfolios and Specifications
13.1.3 Baxter Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 AMRESCO Inc
13.2.1 AMRESCO Inc Company Information
13.2.2 AMRESCO Inc Thrombin (Human) Product Portfolios and Specifications
13.2.3 AMRESCO Inc Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 AMRESCO Inc Main Business Overview
13.2.5 AMRESCO Inc Latest Developments
13.3 BD Biosciences
13.3.1 BD Biosciences Company Information
13.3.2 BD Biosciences Thrombin (Human) Product Portfolios and Specifications
13.3.3 BD Biosciences Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 BD Biosciences Main Business Overview
13.3.5 BD Biosciences Latest Developments
13.4 Life Technologies Corporation
13.4.1 Life Technologies Corporation Company Information
13.4.2 Life Technologies Corporation Thrombin (Human) Product Portfolios and Specifications
13.4.3 Life Technologies Corporation Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Life Technologies Corporation Main Business Overview
13.4.5 Life Technologies Corporation Latest Developments
13.5 PromoCell GmbH
13.5.1 PromoCell GmbH Company Information
13.5.2 PromoCell GmbH Thrombin (Human) Product Portfolios and Specifications
13.5.3 PromoCell GmbH Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 PromoCell GmbH Main Business Overview
13.5.5 PromoCell GmbH Latest Developments
13.6 Sigma-Aldrich Corporation
13.6.1 Sigma-Aldrich Corporation Company Information
13.6.2 Sigma-Aldrich Corporation Thrombin (Human) Product Portfolios and Specifications
13.6.3 Sigma-Aldrich Corporation Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sigma-Aldrich Corporation Main Business Overview
13.6.5 Sigma-Aldrich Corporation Latest Developments
13.7 Vitrolife AB
13.7.1 Vitrolife AB Company Information
13.7.2 Vitrolife AB Thrombin (Human) Product Portfolios and Specifications
13.7.3 Vitrolife AB Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Vitrolife AB Main Business Overview
13.7.5 Vitrolife AB Latest Developments
13.8 CSL
13.8.1 CSL Company Information
13.8.2 CSL Thrombin (Human) Product Portfolios and Specifications
13.8.3 CSL Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 CSL Main Business Overview
13.8.5 CSL Latest Developments
13.9 Bayer
13.9.1 Bayer Company Information
13.9.2 Bayer Thrombin (Human) Product Portfolios and Specifications
13.9.3 Bayer Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Bayer Main Business Overview
13.9.5 Bayer Latest Developments
13.10 Grifols
13.10.1 Grifols Company Information
13.10.2 Grifols Thrombin (Human) Product Portfolios and Specifications
13.10.3 Grifols Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Grifols Main Business Overview
13.10.5 Grifols Latest Developments
13.11 Octapharma
13.11.1 Octapharma Company Information
13.11.2 Octapharma Thrombin (Human) Product Portfolios and Specifications
13.11.3 Octapharma Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Octapharma Main Business Overview
13.11.5 Octapharma Latest Developments
13.12 Shanghai RAAS
13.12.1 Shanghai RAAS Company Information
13.12.2 Shanghai RAAS Thrombin (Human) Product Portfolios and Specifications
13.12.3 Shanghai RAAS Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Shanghai RAAS Main Business Overview
13.12.5 Shanghai RAAS Latest Developments
13.13 Hualan Biological
13.13.1 Hualan Biological Company Information
13.13.2 Hualan Biological Thrombin (Human) Product Portfolios and Specifications
13.13.3 Hualan Biological Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hualan Biological Main Business Overview
13.13.5 Hualan Biological Latest Developments
13.14 Kedrion
13.14.1 Kedrion Company Information
13.14.2 Kedrion Thrombin (Human) Product Portfolios and Specifications
13.14.3 Kedrion Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Kedrion Main Business Overview
13.14.5 Kedrion Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1.Thrombin (Human) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2.Thrombin (Human) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 500IU/Vial
Table 4. Major Players of 1000IU/Vial
Table 5. Major Players of 2500IU/Vial
Table 6. GlobalThrombin (Human) Sales byType (2020-2025) & (K Units)
Table 7. GlobalThrombin (Human) Sales Market Share byType (2020-2025)
Table 8. GlobalThrombin (Human) Revenue byType (2020-2025) & ($ million)
Table 9. GlobalThrombin (Human) Revenue Market Share byType (2020-2025)
Table 10. GlobalThrombin (Human) Sale Price byType (2020-2025) & (USD/Unit)
Table 11. GlobalThrombin (Human) Sale by Application (2020-2025) & (K Units)
Table 12. GlobalThrombin (Human) Sale Market Share by Application (2020-2025)
Table 13. GlobalThrombin (Human) Revenue by Application (2020-2025) & ($ million)
Table 14. GlobalThrombin (Human) Revenue Market Share by Application (2020-2025)
Table 15. GlobalThrombin (Human) Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. GlobalThrombin (Human) Sales by Company (2020-2025) & (K Units)
Table 17. GlobalThrombin (Human) Sales Market Share by Company (2020-2025)
Table 18. GlobalThrombin (Human) Revenue by Company (2020-2025) & ($ millions)
Table 19. GlobalThrombin (Human) Revenue Market Share by Company (2020-2025)
Table 20. GlobalThrombin (Human) Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key ManufacturersThrombin (Human) Producing Area Distribution and Sales Area
Table 22. PlayersThrombin (Human) Products Offered
Table 23.Thrombin (Human) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. GlobalThrombin (Human) Sales by Geographic Region (2020-2025) & (K Units)
Table 27. GlobalThrombin (Human) Sales Market Share Geographic Region (2020-2025)
Table 28. GlobalThrombin (Human) Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. GlobalThrombin (Human) Revenue Market Share by Geographic Region (2020-2025)
Table 30. GlobalThrombin (Human) Sales by Country/Region (2020-2025) & (K Units)
Table 31. GlobalThrombin (Human) Sales Market Share by Country/Region (2020-2025)
Table 32. GlobalThrombin (Human) Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. GlobalThrombin (Human) Revenue Market Share by Country/Region (2020-2025)
Table 34. AmericasThrombin (Human) Sales by Country (2020-2025) & (K Units)
Table 35. AmericasThrombin (Human) Sales Market Share by Country (2020-2025)
Table 36. AmericasThrombin (Human) Revenue by Country (2020-2025) & ($ millions)
Table 37. AmericasThrombin (Human) Sales byType (2020-2025) & (K Units)
Table 38. AmericasThrombin (Human) Sales by Application (2020-2025) & (K Units)
Table 39. APACThrombin (Human) Sales by Region (2020-2025) & (K Units)
Table 40. APACThrombin (Human) Sales Market Share by Region (2020-2025)
Table 41. APACThrombin (Human) Revenue by Region (2020-2025) & ($ millions)
Table 42. APACThrombin (Human) Sales byType (2020-2025) & (K Units)
Table 43. APACThrombin (Human) Sales by Application (2020-2025) & (K Units)
Table 44. EuropeThrombin (Human) Sales by Country (2020-2025) & (K Units)
Table 45. EuropeThrombin (Human) Revenue by Country (2020-2025) & ($ millions)
Table 46. EuropeThrombin (Human) Sales byType (2020-2025) & (K Units)
Table 47. EuropeThrombin (Human) Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & AfricaThrombin (Human) Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & AfricaThrombin (Human) Revenue Market Share by Country (2020-2025)
Table 50. Middle East & AfricaThrombin (Human) Sales byType (2020-2025) & (K Units)
Table 51. Middle East & AfricaThrombin (Human) Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities ofThrombin (Human)
Table 53. Key Market Challenges & Risks ofThrombin (Human)
Table 54. Key IndustryTrends ofThrombin (Human)
Table 55.Thrombin (Human) Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57.Thrombin (Human) Distributors List
Table 58.Thrombin (Human) Customer List
Table 59. GlobalThrombin (Human) SalesForecast by Region (2026-2031) & (K Units)
Table 60. GlobalThrombin (Human) RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. AmericasThrombin (Human) SalesForecast by Country (2026-2031) & (K Units)
Table 62. AmericasThrombin (Human) Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APACThrombin (Human) SalesForecast by Region (2026-2031) & (K Units)
Table 64. APACThrombin (Human) Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. EuropeThrombin (Human) SalesForecast by Country (2026-2031) & (K Units)
Table 66. EuropeThrombin (Human) RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & AfricaThrombin (Human) SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & AfricaThrombin (Human) RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. GlobalThrombin (Human) SalesForecast byType (2026-2031) & (K Units)
Table 70. GlobalThrombin (Human) RevenueForecast byType (2026-2031) & ($ millions)
Table 71. GlobalThrombin (Human) SalesForecast by Application (2026-2031) & (K Units)
Table 72. GlobalThrombin (Human) RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Baxter Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 74. BaxterThrombin (Human) Product Portfolios and Specifications
Table 75. BaxterThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Baxter Main Business
Table 77. Baxter Latest Developments
Table 78. AMRESCO Inc Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 79. AMRESCO IncThrombin (Human) Product Portfolios and Specifications
Table 80. AMRESCO IncThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. AMRESCO Inc Main Business
Table 82. AMRESCO Inc Latest Developments
Table 83. BD Biosciences Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 84. BD BiosciencesThrombin (Human) Product Portfolios and Specifications
Table 85. BD BiosciencesThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. BD Biosciences Main Business
Table 87. BD Biosciences Latest Developments
Table 88. LifeTechnologies Corporation Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 89. LifeTechnologies CorporationThrombin (Human) Product Portfolios and Specifications
Table 90. LifeTechnologies CorporationThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. LifeTechnologies Corporation Main Business
Table 92. LifeTechnologies Corporation Latest Developments
Table 93. PromoCell GmbH Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 94. PromoCell GmbHThrombin (Human) Product Portfolios and Specifications
Table 95. PromoCell GmbHThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. PromoCell GmbH Main Business
Table 97. PromoCell GmbH Latest Developments
Table 98. Sigma-Aldrich Corporation Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 99. Sigma-Aldrich CorporationThrombin (Human) Product Portfolios and Specifications
Table 100. Sigma-Aldrich CorporationThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Sigma-Aldrich Corporation Main Business
Table 102. Sigma-Aldrich Corporation Latest Developments
Table 103. Vitrolife AB Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 104. Vitrolife ABThrombin (Human) Product Portfolios and Specifications
Table 105. Vitrolife ABThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Vitrolife AB Main Business
Table 107. Vitrolife AB Latest Developments
Table 108. CSL Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 109. CSLThrombin (Human) Product Portfolios and Specifications
Table 110. CSLThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. CSL Main Business
Table 112. CSL Latest Developments
Table 113. Bayer Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 114. BayerThrombin (Human) Product Portfolios and Specifications
Table 115. BayerThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Bayer Main Business
Table 117. Bayer Latest Developments
Table 118. Grifols Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 119. GrifolsThrombin (Human) Product Portfolios and Specifications
Table 120. GrifolsThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Grifols Main Business
Table 122. Grifols Latest Developments
Table 123. Octapharma Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 124. OctapharmaThrombin (Human) Product Portfolios and Specifications
Table 125. OctapharmaThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Octapharma Main Business
Table 127. Octapharma Latest Developments
Table 128. Shanghai RAAS Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 129. Shanghai RAASThrombin (Human) Product Portfolios and Specifications
Table 130. Shanghai RAASThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. Shanghai RAAS Main Business
Table 132. Shanghai RAAS Latest Developments
Table 133. Hualan Biological Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 134. Hualan BiologicalThrombin (Human) Product Portfolios and Specifications
Table 135. Hualan BiologicalThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Hualan Biological Main Business
Table 137. Hualan Biological Latest Developments
Table 138. Kedrion Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 139. KedrionThrombin (Human) Product Portfolios and Specifications
Table 140. KedrionThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. Kedrion Main Business
Table 142. Kedrion Latest Developments
LIST OFFIGURES
Figure 1. Picture ofThrombin (Human)
Figure 2.Thrombin (Human) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalThrombin (Human) Sales Growth Rate 2020-2031 (K Units)
Figure 7. GlobalThrombin (Human) Revenue Growth Rate 2020-2031 ($ millions)
Figure 8.Thrombin (Human) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9.Thrombin (Human) Sales Market Share by Country/Region (2024)
Figure 10.Thrombin (Human) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 500IU/Vial
Figure 12. Product Picture of 1000IU/Vial
Figure 13. Product Picture of 2500IU/Vial
Figure 14. GlobalThrombin (Human) Sales Market Share byType in 2025
Figure 15. GlobalThrombin (Human) Revenue Market Share byType (2020-2025)
Figure 16.Thrombin (Human) Consumed in Biotechnology
Figure 17. GlobalThrombin (Human) Market: Biotechnology (2020-2025) & (K Units)
Figure 18.Thrombin (Human) Consumed in Medicine
Figure 19. GlobalThrombin (Human) Market: Medicine (2020-2025) & (K Units)
Figure 20.Thrombin (Human) Consumed in Microbiology
Figure 21. GlobalThrombin (Human) Market: Microbiology (2020-2025) & (K Units)
Figure 22.Thrombin (Human) Consumed in Others
Figure 23. GlobalThrombin (Human) Market: Others (2020-2025) & (K Units)
Figure 24. GlobalThrombin (Human) Sale Market Share by Application (2024)
Figure 25. GlobalThrombin (Human) Revenue Market Share by Application in 2025
Figure 26.Thrombin (Human) Sales by Company in 2025 (K Units)
Figure 27. GlobalThrombin (Human) Sales Market Share by Company in 2025
Figure 28.Thrombin (Human) Revenue by Company in 2025 ($ millions)
Figure 29. GlobalThrombin (Human) Revenue Market Share by Company in 2025
Figure 30. GlobalThrombin (Human) Sales Market Share by Geographic Region (2020-2025)
Figure 31. GlobalThrombin (Human) Revenue Market Share by Geographic Region in 2025
Figure 32. AmericasThrombin (Human) Sales 2020-2025 (K Units)
Figure 33. AmericasThrombin (Human) Revenue 2020-2025 ($ millions)
Figure 34. APACThrombin (Human) Sales 2020-2025 (K Units)
Figure 35. APACThrombin (Human) Revenue 2020-2025 ($ millions)
Figure 36. EuropeThrombin (Human) Sales 2020-2025 (K Units)
Figure 37. EuropeThrombin (Human) Revenue 2020-2025 ($ millions)
Figure 38. Middle East & AfricaThrombin (Human) Sales 2020-2025 (K Units)
Figure 39. Middle East & AfricaThrombin (Human) Revenue 2020-2025 ($ millions)
Figure 40. AmericasThrombin (Human) Sales Market Share by Country in 2025
Figure 41. AmericasThrombin (Human) Revenue Market Share by Country (2020-2025)
Figure 42. AmericasThrombin (Human) Sales Market Share byType (2020-2025)
Figure 43. AmericasThrombin (Human) Sales Market Share by Application (2020-2025)
Figure 44. United StatesThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 45. CanadaThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 46. MexicoThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 47. BrazilThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 48. APACThrombin (Human) Sales Market Share by Region in 2025
Figure 49. APACThrombin (Human) Revenue Market Share by Region (2020-2025)
Figure 50. APACThrombin (Human) Sales Market Share byType (2020-2025)
Figure 51. APACThrombin (Human) Sales Market Share by Application (2020-2025)
Figure 52. ChinaThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 53. JapanThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 54. South KoreaThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast AsiaThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 56. IndiaThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 57. AustraliaThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 58. ChinaTaiwanThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 59. EuropeThrombin (Human) Sales Market Share by Country in 2025
Figure 60. EuropeThrombin (Human) Revenue Market Share by Country (2020-2025)
Figure 61. EuropeThrombin (Human) Sales Market Share byType (2020-2025)
Figure 62. EuropeThrombin (Human) Sales Market Share by Application (2020-2025)
Figure 63. GermanyThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 64.FranceThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 65. UKThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 66. ItalyThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 67. RussiaThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & AfricaThrombin (Human) Sales Market Share by Country (2020-2025)
Figure 69. Middle East & AfricaThrombin (Human) Sales Market Share byType (2020-2025)
Figure 70. Middle East & AfricaThrombin (Human) Sales Market Share by Application (2020-2025)
Figure 71. EgyptThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 72. South AfricaThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 73. IsraelThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 74.TurkeyThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC CountriesThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis ofThrombin (Human) in 2025
Figure 77. Manufacturing Process Analysis ofThrombin (Human)
Figure 78. Industry Chain Structure ofThrombin (Human)
Figure 79. Channels of Distribution
Figure 80. GlobalThrombin (Human) Sales MarketForecast by Region (2026-2031)
Figure 81. GlobalThrombin (Human) Revenue Market ShareForecast by Region (2026-2031)
Figure 82. GlobalThrombin (Human) Sales Market ShareForecast byType (2026-2031)
Figure 83. GlobalThrombin (Human) Revenue Market ShareForecast byType (2026-2031)
Figure 84. GlobalThrombin (Human) Sales Market ShareForecast by Application (2026-2031)
Figure 85. GlobalThrombin (Human) Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Thrombin (Human) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Thrombin (Human) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Thrombin (Human) by Country/Region, 2020, 2024 & 2031
2.2 Thrombin (Human) Segment by Type
2.2.1 500IU/Vial
2.2.2 1000IU/Vial
2.2.3 2500IU/Vial
2.3 Thrombin (Human) Sales by Type
2.3.1 Global Thrombin (Human) Sales Market Share by Type (2020-2025)
2.3.2 Global Thrombin (Human) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Thrombin (Human) Sale Price by Type (2020-2025)
2.4 Thrombin (Human) Segment by Application
2.4.1 Biotechnology
2.4.2 Medicine
2.4.3 Microbiology
2.4.4 Others
2.5 Thrombin (Human) Sales by Application
2.5.1 Global Thrombin (Human) Sale Market Share by Application (2020-2025)
2.5.2 Global Thrombin (Human) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Thrombin (Human) Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Thrombin (Human) Breakdown Data by Company
3.1.1 Global Thrombin (Human) Annual Sales by Company (2020-2025)
3.1.2 Global Thrombin (Human) Sales Market Share by Company (2020-2025)
3.2 Global Thrombin (Human) Annual Revenue by Company (2020-2025)
3.2.1 Global Thrombin (Human) Revenue by Company (2020-2025)
3.2.2 Global Thrombin (Human) Revenue Market Share by Company (2020-2025)
3.3 Global Thrombin (Human) Sale Price by Company
3.4 Key Manufacturers Thrombin (Human) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Thrombin (Human) Product Location Distribution
3.4.2 Players Thrombin (Human) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR THROMBIN (HUMAN) BY GEOGRAPHIC REGION
4.1 World Historic Thrombin (Human) Market Size by Geographic Region (2020-2025)
4.1.1 Global Thrombin (Human) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Thrombin (Human) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Thrombin (Human) Market Size by Country/Region (2020-2025)
4.2.1 Global Thrombin (Human) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Thrombin (Human) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Thrombin (Human) Sales Growth
4.4 APAC Thrombin (Human) Sales Growth
4.5 Europe Thrombin (Human) Sales Growth
4.6 Middle East & Africa Thrombin (Human) Sales Growth
5 AMERICAS
5.1 Americas Thrombin (Human) Sales by Country
5.1.1 Americas Thrombin (Human) Sales by Country (2020-2025)
5.1.2 Americas Thrombin (Human) Revenue by Country (2020-2025)
5.2 Americas Thrombin (Human) Sales by Type (2020-2025)
5.3 Americas Thrombin (Human) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Thrombin (Human) Sales by Region
6.1.1 APAC Thrombin (Human) Sales by Region (2020-2025)
6.1.2 APAC Thrombin (Human) Revenue by Region (2020-2025)
6.2 APAC Thrombin (Human) Sales by Type (2020-2025)
6.3 APAC Thrombin (Human) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Thrombin (Human) by Country
7.1.1 Europe Thrombin (Human) Sales by Country (2020-2025)
7.1.2 Europe Thrombin (Human) Revenue by Country (2020-2025)
7.2 Europe Thrombin (Human) Sales by Type (2020-2025)
7.3 Europe Thrombin (Human) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Thrombin (Human) by Country
8.1.1 Middle East & Africa Thrombin (Human) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Thrombin (Human) Revenue by Country (2020-2025)
8.2 Middle East & Africa Thrombin (Human) Sales by Type (2020-2025)
8.3 Middle East & Africa Thrombin (Human) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Thrombin (Human)
10.3 Manufacturing Process Analysis of Thrombin (Human)
10.4 Industry Chain Structure of Thrombin (Human)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Thrombin (Human) Distributors
11.3 Thrombin (Human) Customer
12 WORLD FORECAST REVIEW FOR THROMBIN (HUMAN) BY GEOGRAPHIC REGION
12.1 Global Thrombin (Human) Market Size Forecast by Region
12.1.1 Global Thrombin (Human) Forecast by Region (2026-2031)
12.1.2 Global Thrombin (Human) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Thrombin (Human) Forecast by Type (2026-2031)
12.7 Global Thrombin (Human) Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Thrombin (Human) Product Portfolios and Specifications
13.1.3 Baxter Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 AMRESCO Inc
13.2.1 AMRESCO Inc Company Information
13.2.2 AMRESCO Inc Thrombin (Human) Product Portfolios and Specifications
13.2.3 AMRESCO Inc Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 AMRESCO Inc Main Business Overview
13.2.5 AMRESCO Inc Latest Developments
13.3 BD Biosciences
13.3.1 BD Biosciences Company Information
13.3.2 BD Biosciences Thrombin (Human) Product Portfolios and Specifications
13.3.3 BD Biosciences Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 BD Biosciences Main Business Overview
13.3.5 BD Biosciences Latest Developments
13.4 Life Technologies Corporation
13.4.1 Life Technologies Corporation Company Information
13.4.2 Life Technologies Corporation Thrombin (Human) Product Portfolios and Specifications
13.4.3 Life Technologies Corporation Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Life Technologies Corporation Main Business Overview
13.4.5 Life Technologies Corporation Latest Developments
13.5 PromoCell GmbH
13.5.1 PromoCell GmbH Company Information
13.5.2 PromoCell GmbH Thrombin (Human) Product Portfolios and Specifications
13.5.3 PromoCell GmbH Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 PromoCell GmbH Main Business Overview
13.5.5 PromoCell GmbH Latest Developments
13.6 Sigma-Aldrich Corporation
13.6.1 Sigma-Aldrich Corporation Company Information
13.6.2 Sigma-Aldrich Corporation Thrombin (Human) Product Portfolios and Specifications
13.6.3 Sigma-Aldrich Corporation Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sigma-Aldrich Corporation Main Business Overview
13.6.5 Sigma-Aldrich Corporation Latest Developments
13.7 Vitrolife AB
13.7.1 Vitrolife AB Company Information
13.7.2 Vitrolife AB Thrombin (Human) Product Portfolios and Specifications
13.7.3 Vitrolife AB Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Vitrolife AB Main Business Overview
13.7.5 Vitrolife AB Latest Developments
13.8 CSL
13.8.1 CSL Company Information
13.8.2 CSL Thrombin (Human) Product Portfolios and Specifications
13.8.3 CSL Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 CSL Main Business Overview
13.8.5 CSL Latest Developments
13.9 Bayer
13.9.1 Bayer Company Information
13.9.2 Bayer Thrombin (Human) Product Portfolios and Specifications
13.9.3 Bayer Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Bayer Main Business Overview
13.9.5 Bayer Latest Developments
13.10 Grifols
13.10.1 Grifols Company Information
13.10.2 Grifols Thrombin (Human) Product Portfolios and Specifications
13.10.3 Grifols Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Grifols Main Business Overview
13.10.5 Grifols Latest Developments
13.11 Octapharma
13.11.1 Octapharma Company Information
13.11.2 Octapharma Thrombin (Human) Product Portfolios and Specifications
13.11.3 Octapharma Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Octapharma Main Business Overview
13.11.5 Octapharma Latest Developments
13.12 Shanghai RAAS
13.12.1 Shanghai RAAS Company Information
13.12.2 Shanghai RAAS Thrombin (Human) Product Portfolios and Specifications
13.12.3 Shanghai RAAS Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Shanghai RAAS Main Business Overview
13.12.5 Shanghai RAAS Latest Developments
13.13 Hualan Biological
13.13.1 Hualan Biological Company Information
13.13.2 Hualan Biological Thrombin (Human) Product Portfolios and Specifications
13.13.3 Hualan Biological Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hualan Biological Main Business Overview
13.13.5 Hualan Biological Latest Developments
13.14 Kedrion
13.14.1 Kedrion Company Information
13.14.2 Kedrion Thrombin (Human) Product Portfolios and Specifications
13.14.3 Kedrion Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Kedrion Main Business Overview
13.14.5 Kedrion Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1.Thrombin (Human) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2.Thrombin (Human) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 500IU/Vial
Table 4. Major Players of 1000IU/Vial
Table 5. Major Players of 2500IU/Vial
Table 6. GlobalThrombin (Human) Sales byType (2020-2025) & (K Units)
Table 7. GlobalThrombin (Human) Sales Market Share byType (2020-2025)
Table 8. GlobalThrombin (Human) Revenue byType (2020-2025) & ($ million)
Table 9. GlobalThrombin (Human) Revenue Market Share byType (2020-2025)
Table 10. GlobalThrombin (Human) Sale Price byType (2020-2025) & (USD/Unit)
Table 11. GlobalThrombin (Human) Sale by Application (2020-2025) & (K Units)
Table 12. GlobalThrombin (Human) Sale Market Share by Application (2020-2025)
Table 13. GlobalThrombin (Human) Revenue by Application (2020-2025) & ($ million)
Table 14. GlobalThrombin (Human) Revenue Market Share by Application (2020-2025)
Table 15. GlobalThrombin (Human) Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. GlobalThrombin (Human) Sales by Company (2020-2025) & (K Units)
Table 17. GlobalThrombin (Human) Sales Market Share by Company (2020-2025)
Table 18. GlobalThrombin (Human) Revenue by Company (2020-2025) & ($ millions)
Table 19. GlobalThrombin (Human) Revenue Market Share by Company (2020-2025)
Table 20. GlobalThrombin (Human) Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key ManufacturersThrombin (Human) Producing Area Distribution and Sales Area
Table 22. PlayersThrombin (Human) Products Offered
Table 23.Thrombin (Human) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. GlobalThrombin (Human) Sales by Geographic Region (2020-2025) & (K Units)
Table 27. GlobalThrombin (Human) Sales Market Share Geographic Region (2020-2025)
Table 28. GlobalThrombin (Human) Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. GlobalThrombin (Human) Revenue Market Share by Geographic Region (2020-2025)
Table 30. GlobalThrombin (Human) Sales by Country/Region (2020-2025) & (K Units)
Table 31. GlobalThrombin (Human) Sales Market Share by Country/Region (2020-2025)
Table 32. GlobalThrombin (Human) Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. GlobalThrombin (Human) Revenue Market Share by Country/Region (2020-2025)
Table 34. AmericasThrombin (Human) Sales by Country (2020-2025) & (K Units)
Table 35. AmericasThrombin (Human) Sales Market Share by Country (2020-2025)
Table 36. AmericasThrombin (Human) Revenue by Country (2020-2025) & ($ millions)
Table 37. AmericasThrombin (Human) Sales byType (2020-2025) & (K Units)
Table 38. AmericasThrombin (Human) Sales by Application (2020-2025) & (K Units)
Table 39. APACThrombin (Human) Sales by Region (2020-2025) & (K Units)
Table 40. APACThrombin (Human) Sales Market Share by Region (2020-2025)
Table 41. APACThrombin (Human) Revenue by Region (2020-2025) & ($ millions)
Table 42. APACThrombin (Human) Sales byType (2020-2025) & (K Units)
Table 43. APACThrombin (Human) Sales by Application (2020-2025) & (K Units)
Table 44. EuropeThrombin (Human) Sales by Country (2020-2025) & (K Units)
Table 45. EuropeThrombin (Human) Revenue by Country (2020-2025) & ($ millions)
Table 46. EuropeThrombin (Human) Sales byType (2020-2025) & (K Units)
Table 47. EuropeThrombin (Human) Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & AfricaThrombin (Human) Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & AfricaThrombin (Human) Revenue Market Share by Country (2020-2025)
Table 50. Middle East & AfricaThrombin (Human) Sales byType (2020-2025) & (K Units)
Table 51. Middle East & AfricaThrombin (Human) Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities ofThrombin (Human)
Table 53. Key Market Challenges & Risks ofThrombin (Human)
Table 54. Key IndustryTrends ofThrombin (Human)
Table 55.Thrombin (Human) Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57.Thrombin (Human) Distributors List
Table 58.Thrombin (Human) Customer List
Table 59. GlobalThrombin (Human) SalesForecast by Region (2026-2031) & (K Units)
Table 60. GlobalThrombin (Human) RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. AmericasThrombin (Human) SalesForecast by Country (2026-2031) & (K Units)
Table 62. AmericasThrombin (Human) Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APACThrombin (Human) SalesForecast by Region (2026-2031) & (K Units)
Table 64. APACThrombin (Human) Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. EuropeThrombin (Human) SalesForecast by Country (2026-2031) & (K Units)
Table 66. EuropeThrombin (Human) RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & AfricaThrombin (Human) SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & AfricaThrombin (Human) RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. GlobalThrombin (Human) SalesForecast byType (2026-2031) & (K Units)
Table 70. GlobalThrombin (Human) RevenueForecast byType (2026-2031) & ($ millions)
Table 71. GlobalThrombin (Human) SalesForecast by Application (2026-2031) & (K Units)
Table 72. GlobalThrombin (Human) RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Baxter Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 74. BaxterThrombin (Human) Product Portfolios and Specifications
Table 75. BaxterThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Baxter Main Business
Table 77. Baxter Latest Developments
Table 78. AMRESCO Inc Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 79. AMRESCO IncThrombin (Human) Product Portfolios and Specifications
Table 80. AMRESCO IncThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. AMRESCO Inc Main Business
Table 82. AMRESCO Inc Latest Developments
Table 83. BD Biosciences Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 84. BD BiosciencesThrombin (Human) Product Portfolios and Specifications
Table 85. BD BiosciencesThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. BD Biosciences Main Business
Table 87. BD Biosciences Latest Developments
Table 88. LifeTechnologies Corporation Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 89. LifeTechnologies CorporationThrombin (Human) Product Portfolios and Specifications
Table 90. LifeTechnologies CorporationThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. LifeTechnologies Corporation Main Business
Table 92. LifeTechnologies Corporation Latest Developments
Table 93. PromoCell GmbH Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 94. PromoCell GmbHThrombin (Human) Product Portfolios and Specifications
Table 95. PromoCell GmbHThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. PromoCell GmbH Main Business
Table 97. PromoCell GmbH Latest Developments
Table 98. Sigma-Aldrich Corporation Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 99. Sigma-Aldrich CorporationThrombin (Human) Product Portfolios and Specifications
Table 100. Sigma-Aldrich CorporationThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Sigma-Aldrich Corporation Main Business
Table 102. Sigma-Aldrich Corporation Latest Developments
Table 103. Vitrolife AB Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 104. Vitrolife ABThrombin (Human) Product Portfolios and Specifications
Table 105. Vitrolife ABThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Vitrolife AB Main Business
Table 107. Vitrolife AB Latest Developments
Table 108. CSL Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 109. CSLThrombin (Human) Product Portfolios and Specifications
Table 110. CSLThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. CSL Main Business
Table 112. CSL Latest Developments
Table 113. Bayer Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 114. BayerThrombin (Human) Product Portfolios and Specifications
Table 115. BayerThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Bayer Main Business
Table 117. Bayer Latest Developments
Table 118. Grifols Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 119. GrifolsThrombin (Human) Product Portfolios and Specifications
Table 120. GrifolsThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Grifols Main Business
Table 122. Grifols Latest Developments
Table 123. Octapharma Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 124. OctapharmaThrombin (Human) Product Portfolios and Specifications
Table 125. OctapharmaThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Octapharma Main Business
Table 127. Octapharma Latest Developments
Table 128. Shanghai RAAS Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 129. Shanghai RAASThrombin (Human) Product Portfolios and Specifications
Table 130. Shanghai RAASThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. Shanghai RAAS Main Business
Table 132. Shanghai RAAS Latest Developments
Table 133. Hualan Biological Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 134. Hualan BiologicalThrombin (Human) Product Portfolios and Specifications
Table 135. Hualan BiologicalThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Hualan Biological Main Business
Table 137. Hualan Biological Latest Developments
Table 138. Kedrion Basic Information,Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 139. KedrionThrombin (Human) Product Portfolios and Specifications
Table 140. KedrionThrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. Kedrion Main Business
Table 142. Kedrion Latest Developments
LIST OFFIGURES
Figure 1. Picture ofThrombin (Human)
Figure 2.Thrombin (Human) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalThrombin (Human) Sales Growth Rate 2020-2031 (K Units)
Figure 7. GlobalThrombin (Human) Revenue Growth Rate 2020-2031 ($ millions)
Figure 8.Thrombin (Human) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9.Thrombin (Human) Sales Market Share by Country/Region (2024)
Figure 10.Thrombin (Human) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 500IU/Vial
Figure 12. Product Picture of 1000IU/Vial
Figure 13. Product Picture of 2500IU/Vial
Figure 14. GlobalThrombin (Human) Sales Market Share byType in 2025
Figure 15. GlobalThrombin (Human) Revenue Market Share byType (2020-2025)
Figure 16.Thrombin (Human) Consumed in Biotechnology
Figure 17. GlobalThrombin (Human) Market: Biotechnology (2020-2025) & (K Units)
Figure 18.Thrombin (Human) Consumed in Medicine
Figure 19. GlobalThrombin (Human) Market: Medicine (2020-2025) & (K Units)
Figure 20.Thrombin (Human) Consumed in Microbiology
Figure 21. GlobalThrombin (Human) Market: Microbiology (2020-2025) & (K Units)
Figure 22.Thrombin (Human) Consumed in Others
Figure 23. GlobalThrombin (Human) Market: Others (2020-2025) & (K Units)
Figure 24. GlobalThrombin (Human) Sale Market Share by Application (2024)
Figure 25. GlobalThrombin (Human) Revenue Market Share by Application in 2025
Figure 26.Thrombin (Human) Sales by Company in 2025 (K Units)
Figure 27. GlobalThrombin (Human) Sales Market Share by Company in 2025
Figure 28.Thrombin (Human) Revenue by Company in 2025 ($ millions)
Figure 29. GlobalThrombin (Human) Revenue Market Share by Company in 2025
Figure 30. GlobalThrombin (Human) Sales Market Share by Geographic Region (2020-2025)
Figure 31. GlobalThrombin (Human) Revenue Market Share by Geographic Region in 2025
Figure 32. AmericasThrombin (Human) Sales 2020-2025 (K Units)
Figure 33. AmericasThrombin (Human) Revenue 2020-2025 ($ millions)
Figure 34. APACThrombin (Human) Sales 2020-2025 (K Units)
Figure 35. APACThrombin (Human) Revenue 2020-2025 ($ millions)
Figure 36. EuropeThrombin (Human) Sales 2020-2025 (K Units)
Figure 37. EuropeThrombin (Human) Revenue 2020-2025 ($ millions)
Figure 38. Middle East & AfricaThrombin (Human) Sales 2020-2025 (K Units)
Figure 39. Middle East & AfricaThrombin (Human) Revenue 2020-2025 ($ millions)
Figure 40. AmericasThrombin (Human) Sales Market Share by Country in 2025
Figure 41. AmericasThrombin (Human) Revenue Market Share by Country (2020-2025)
Figure 42. AmericasThrombin (Human) Sales Market Share byType (2020-2025)
Figure 43. AmericasThrombin (Human) Sales Market Share by Application (2020-2025)
Figure 44. United StatesThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 45. CanadaThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 46. MexicoThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 47. BrazilThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 48. APACThrombin (Human) Sales Market Share by Region in 2025
Figure 49. APACThrombin (Human) Revenue Market Share by Region (2020-2025)
Figure 50. APACThrombin (Human) Sales Market Share byType (2020-2025)
Figure 51. APACThrombin (Human) Sales Market Share by Application (2020-2025)
Figure 52. ChinaThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 53. JapanThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 54. South KoreaThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast AsiaThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 56. IndiaThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 57. AustraliaThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 58. ChinaTaiwanThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 59. EuropeThrombin (Human) Sales Market Share by Country in 2025
Figure 60. EuropeThrombin (Human) Revenue Market Share by Country (2020-2025)
Figure 61. EuropeThrombin (Human) Sales Market Share byType (2020-2025)
Figure 62. EuropeThrombin (Human) Sales Market Share by Application (2020-2025)
Figure 63. GermanyThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 64.FranceThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 65. UKThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 66. ItalyThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 67. RussiaThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & AfricaThrombin (Human) Sales Market Share by Country (2020-2025)
Figure 69. Middle East & AfricaThrombin (Human) Sales Market Share byType (2020-2025)
Figure 70. Middle East & AfricaThrombin (Human) Sales Market Share by Application (2020-2025)
Figure 71. EgyptThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 72. South AfricaThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 73. IsraelThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 74.TurkeyThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC CountriesThrombin (Human) Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis ofThrombin (Human) in 2025
Figure 77. Manufacturing Process Analysis ofThrombin (Human)
Figure 78. Industry Chain Structure ofThrombin (Human)
Figure 79. Channels of Distribution
Figure 80. GlobalThrombin (Human) Sales MarketForecast by Region (2026-2031)
Figure 81. GlobalThrombin (Human) Revenue Market ShareForecast by Region (2026-2031)
Figure 82. GlobalThrombin (Human) Sales Market ShareForecast byType (2026-2031)
Figure 83. GlobalThrombin (Human) Revenue Market ShareForecast byType (2026-2031)
Figure 84. GlobalThrombin (Human) Sales Market ShareForecast by Application (2026-2031)
Figure 85. GlobalThrombin (Human) Revenue Market ShareForecast by Application (2026-2031)
